abstract |
(57) [Summary] [Object] To provide a method for inhibiting viral infectivity in a subject and a method for preventing or treating viral infection in a subject. A pharmaceutical composition containing HBNF, MK, or both, useful in blocking infection of a virus characterized by the presence of a heparin-binding protein. |